home All News open_in_new Full Article

Notice of Knight Therapeutics’ Fourth Quarter and Year End 2024 Results Conference Call

MONTREAL, March 13, 2025 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-USA) specialty pharmaceutical company, will release its fourth quarter and year end 2024 financial results on Thursday, March 20, 2025 prior to market opening. Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all […]



Knight Therapeutics Inc. (TSX: GUD) will release its Q4 and year-end 2024 financial results on March 20, 2025, prior to market opening, followed by a conference call and audio webcast. The call can be accessed toll-free at 1-888-699-1199 or internationally at 1-416-945-7677, with a webcast available at www.knighttx.com. An archived replay will be available for 30 days on the website. Knight Therapeutics is a pan-American (ex-USA) specialty pharmaceutical company.

today 19 h. ago attach_file Culture

attach_file Economics
attach_file Economics
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Economics
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture


ID: 370307537
Add Watch Country

arrow_drop_down